Among the most significantly affected top 10 DEGs, CD36 and IGFBP2 are highly associated with MASLD development (Hedbacker et al, 2010; Wilson et al, 2016) (Fig. 4A,B). The gene discussed is IGFBP2; the disease is metabolic dysfunction-associated steatotic liver disease.